A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism

Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney Transplantation

(2013) P. Perrin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients

(2013) Pieter Evenepoel   SEMINARS IN NEPHROLOGY

Calcium and Osteoprotegerin Levels Predict the Progression of the Abdominal Aortic Calcifications After Kidney Transplantation

(2013) Maria Meneghini et al.   TRANSPLANTATION

Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo

(2012) Stephen J. Quinn et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Calcium Deficiency Reduces Circulating Levels of FGF23

(2012) M. E. Rodriguez-Ortiz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Cinacalcet de Novo in Persistent Hypercalcemia After Kidney Transplantation Secondary to Hyperparathyroidism: Long-Term Follow-up and Effect of Withdrawal

(2012) R.P. Paschoalin et al.   TRANSPLANTATION PROCEEDINGS

Progression of Coronary Artery Calcification and Thoracic Aorta Calcification in Kidney Transplant Recipients

(2011) Céline Maréchal et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options

(2011) J. Cunningham et al.   Clinical Journal of the American Society of Nephrology

Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation

(2011) L.R.S. Pinho et al.   CLINICAL NEPHROLOGY

Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels

(2011) Andrea Trombetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up

(2011) Hazim M. Sadideen et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality

(2011) M. Wolf et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renal Function in Patients Treated with Cinacalcet for Persistent Hyperparathyroidism after Kidney Transplantation

(2011) Jana Henschkowski et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Cinacalcet Decreases Bone Formation Rate in Hypercalcemic Hyperparathyroidism after Kidney Transplantation

(2010) Kyra A. Borchhardt et al.   AMERICAN JOURNAL OF NEPHROLOGY

Treatment of Hyperparathyroidism With Cinacalcet in Kidney Transplant Recipients

(2010) S. Borstnar et al.   TRANSPLANTATION PROCEEDINGS

Progression of Coronary Artery Calcification in Renal Transplantation and the Role of Secondary Hyperparathyroidism and Inflammation

(2009) S. Mazzaferro et al.   Clinical Journal of the American Society of Nephrology

Risk of Fractures After Renal Transplantation in the United States

(2009) Lucas E. Nikkel et al.   TRANSPLANTATION

Evolution of Secondary Hyperparathyroidism After Kidney Transplantation in Patients Receiving Cinacalcet on Dialysis

(2009) J.-V. Torregrosa et al.   TRANSPLANTATION PROCEEDINGS

Phosphatemic Effect of Cinacalcet in Kidney Transplant Recipients With Persistent Hyperparathyroidism

(2008) Andreas L. Serra et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism

(2008) G. A. Block et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION